Seizures Dramatically Reshape the Brain's Opioid Peptide Balance in the Hippocampus
Seizures initially release both enkephalin and dynorphin, but long-term they increase enkephalin production while drastically reducing dynorphin — potentially altering future seizure susceptibility.
Quick Facts
What This Study Found
Both seizure types caused initial opioid release. Long-term: enkephalin biosynthesis increased, dynorphin biosynthesis drastically decreased. These peptides are in distinct hippocampal pathways.
Key Numbers
How They Did This
Molecular biology approach measuring mRNA levels and peptide content for prodynorphin and proenkephalin in rat hippocampus after electroconvulsive shocks and amygdala kindling.
Why This Research Matters
The opposite long-term changes in enkephalin vs. dynorphin could affect whether the brain becomes more or less susceptible to future seizures. This has implications for epilepsy treatment.
The Bigger Picture
Epilepsy often worsens over time — a process called kindling. The finding that seizures deplete dynorphin (which normally inhibits excitatory signaling) while boosting enkephalin could help explain why the brain becomes progressively more seizure-prone.
What This Study Doesn't Tell Us
Animal study using experimental seizure models. The electroconvulsive and kindling models may not perfectly represent human epilepsy. Only hippocampus studied.
Questions This Raises
- ?Could restoring dynorphin levels after seizures help prevent epilepsy progression?
- ?Does the enkephalin increase serve a protective or harmful role in seizure susceptibility?
Trust & Context
- Key Stat:
- Opposite long-term changes Seizures increased enkephalin but drastically decreased dynorphin biosynthesis — two opioids moving in opposite directions
- Evidence Grade:
- Preliminary — animal study using electroconvulsive and kindling seizure models. Molecular biology approach provides mechanistic detail but uses experimental, not natural, seizures.
- Study Age:
- Published in 1992 (34 years ago). The role of opioid peptides in epilepsy is now well-established, building on findings like these.
- Original Title:
- Hippocampal opioid peptides and seizures.
- Published In:
- Epilepsy research. Supplement, 7, 187-95 (1992)
- Authors:
- Hong, J S(5)
- Database ID:
- RPEP-00237
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why do seizures change opioid peptide levels?
Seizures cause massive neural activity that depletes stored peptides. The brain then tries to replenish them, but enkephalin and dynorphin recover differently — enkephalin production ramps up while dynorphin production collapses.
Could this explain why epilepsy gets worse over time?
Possibly. Dynorphin normally acts as a brake on excitatory brain activity. If seizures deplete dynorphin long-term, the brain loses a key protective mechanism, potentially making future seizures more likely and severe.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00237APA
Hong, J S. (1992). Hippocampal opioid peptides and seizures.. Epilepsy research. Supplement, 7, 187-95.
MLA
Hong, J S. "Hippocampal opioid peptides and seizures.." Epilepsy research. Supplement, 1992.
RethinkPeptides
RethinkPeptides Research Database. "Hippocampal opioid peptides and seizures." RPEP-00237. Retrieved from https://rethinkpeptides.com/research/hong-1992-hippocampal-opioid-peptides-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.